David G. Parkes

Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies

Jonathan D. Roth, Barbara Roland, Rebecca L. Cole et al. · Proceedings of the National Academy of Sciences · 2008 · 426 citations · Full text

Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice

James L. Trevaskis, Peter S. Griffin, Carrie Wittmer et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2012 · 271 citations

Immunology, Pathology, Fatty Liver Disease +22

Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro

David G. Parkes, Richard Pittner, Carolyn M. Jodka et al. · Metabolism · 2001 · 242 citations

Gastrointestinal Peptide Hormone, Molecular Physiology, Biochemistry +10

Exenatide (Exendin-4) Improves Insulin Sensitivity and β-Cell Mass in Insulin-Resistant Obese<i>fa/fa</i>Zucker Rats Independent of Glycemia and Body Weight

Bronislava Gedulin, Svetlana E. Nikoulina, Pam Smith et al. · Endocrinology · 2004 · 239 citations

Nutrition, Metabolic Disorder, Con Rats +22

Effects of PYY[3–36] in rodent models of diabetes and obesity

Richard Pittner, Candace X. Moore, Sunil Bhavsar et al. · International Journal of Obesity · 2004 · 219 citations

Obesity, Caloric Restriction, Metabolic Syndrome +14